I

Iterum Therapeutics plc
D

ITRM

2.04500
USD
0.07
(3.54%)
مغلق
حجم التداول
20,659
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
56,270,069
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    G
    GNPX
    -0.03500
    (-2.16%)
    1.58500 USD
    M
    MARK
    0
    (0%)
    0.000000 USD
    M
    MVIS
    -0.06830
    (-7.13%)
    0.89020 USD
    PLTR
    PLTR
    6.580
    (11.11%)
    65.780 USD
    S
    SNDL
    0.00500
    (0.26%)
    1.95500 USD
    S
    SOS
    -0.02010
    (-2.45%)
    0.80010 USD
    T
    TTOO
    -0.00300
    (-0.57%)
    0.52000 USD
    Z
    ZOM
    -0.00460
    (-3.30%)
    0.13490 USD
    المزيد
الأخبار

العنوان: Iterum Therapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.